Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantK
Kinnevik
Activity from announced rounds
Activity in this selectionOct 19, 2026 · Jul 22, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $411M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionTandem Health
Tandem builds an AI clinical assistant that turns patient consultations and clinician dictation into draft notes and follow-up documents for review in existing medical-record systems.
$100MSeries B
Participant